China Grand Pharmaceutical and Healthcare Holdings
China Grand Pharmaceutical and Healthcare Holdings Limited.
Launch date
Employees
Market cap
€1.7b
Enterprise valuation
€1.8b (Public information from Sep 2024)
Share price
HKD4.3 0512.HK
Central and Western District Hong Kong Island (HQ)
Financials
Estimates*
| HKD | 2019 | 2020 | 2021 | 2022 | 2023 | 2025 |
|---|---|---|---|---|---|---|
| Revenues | 6.6b | 6.4b | 8.6b | 9.6b | 10.5b | 112.7b |
| % growth | - | (4 %) | 35 % | 11 % | 10 % | - |
| EBITDA | 2.0b | 2.2b | 2.7b | 3.1b | 3.2b | - |
| % EBITDA margin | 31 % | 35 % | 32 % | 32 % | 30 % | - |
| Profit | 1.2b | 1.8b | 2.4b | 2.1b | 1.9b | - |
| % profit margin | 17 % | 28 % | 28 % | 22 % | 18 % | - |
| Date | Investors | Amount | Round |
|---|---|---|---|
| N/A | N/A | IPO | |
| Total Funding | - | ||
Related Content
Recent News about China Grand Pharmaceutical and Healthcare Holdings
EditTech stack
Tech stackLearn more about the technologies and tools that this company uses.
Investments by China Grand Pharmaceutical and Healthcare Holdings
Edit
ACQUISITION by China Grand Pharmaceutical and Healthcare Holdings Apr 2023